As a recent study demonstrated that PTEN negative was a poor prognostic factor for all patients with gastric cancer27, it might be necessary to consider personalized treatment for PTEN-negative gastric cancer regardless of HER2 expression. Here, ERBB2 is linked to gastric cancer.